Halozyme Therapeutics, Inc. (HALO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Halozyme Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 25.45x | 13.65x | 17.32x | 38.52x | 14.04x | 45.07x |
| P/B Ratio | 165.22x | 16.67x | 58.18x | 45.86x | 28.71x | 38.51x |
| P/S Ratio | 5.77x | 5.97x | 5.88x | 11.80x | 12.76x | 21.74x |
| Profitability | ||||||
| Gross Margin | 78.1% | 84.3% | 76.8% | 78.9% | 81.6% | 83.8% |
| Operating Margin | 58.4% | 54.3% | 40.7% | 40.5% | 62.2% | 53.9% |
| Net Margin | 22.7% | 43.7% | 34.0% | 30.6% | 90.8% | 48.2% |
| EBITDA Margin | 64.8% | 64.7% | 54.5% | 47.8% | 58.4% | 57.2% |
| Liquidity | ||||||
| Current Ratio | 4.66x | 7.80x | 6.64x | 5.65x | 7.91x | 1.32x |
| Quick Ratio | 3.66x | 6.78x | 5.50x | 4.88x | 7.45x | 1.17x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 4.14x | 17.89x | 8.87x | 4.45x | 2.63x |
YoY = year-over-year change. Source: FMP..